Wyeth-Ayerst Neumega Pediatric Labeling Adds Papilledema Warning
Executive Summary
Wyeth-Ayerst is revising its label for Neumega (oprelvekin, recombinant interleukin-11) following preliminary results from a pediatric safety and pharmacokinetic study.